The Economics of Topical Immunomodulators for the Treatment of Atopic Dermatitis

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.23, Iss.6, 2005-01, pp. : 543-566

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Topical use of corticosteroids and calcineurin inhibitors is the key to effective treatment of atopic dermatitis

By Adis International Limited

Drugs & Therapy Perspectives, Vol. 25, Iss. 3, 2009-03 ,pp. : 10-13

Adis International

Access to resources Recommend Favorite

New Treatment Modalities for Vitiligo: Focus on Topical Immunomodulators

By Kresimir Kostovic Aida Pasic

Drugs, Vol. 65, Iss. 4, 2005-01 ,pp. : 447-459

Adis International

Access to resources Recommend Favorite

Treatment of Atopic Dermatitis and Impact on Quality of Life: A Review with Emphasis on Topical Non-Corticosteroids

By Schiffner R.

PharmacoEconomics, Vol. 21, Iss. 3, 2003-01 ,pp. : 159-179

Adis International

Access to resources Recommend Favorite

Topical tacrolimus itching to succeed in atopic dermatitis

Inpharma, Vol. 1, Iss. 1234, 2000-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite

Role of Topical Calcineurin Inhibitors on Atopic Dermatitis of Children

Current Medicinal Chemistry, Vol. 14, Iss. 14, 2007-06 ,pp. : 1579-1591

Bentham Science Publishers

Access to resources Recommend Favorite